Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.
Mileto D, Fenizia C, Cutrera M, Gagliardi G, Gigantiello A, De Silvestri A, Rizzo A, Mancon A, Bianchi M, De Poli F, Cuomo M, Burgo I, Longo M, Rimoldi SG, Pagani C, Grosso S, Micheli V, Rizzardini G, Grande R, Biasin M, Gismondo MR, Lombardi A. Mileto D, et al. Among authors: micheli v. Emerg Microbes Infect. 2021 Dec;10(1):2235-2243. doi: 10.1080/22221751.2021.2004866. Emerg Microbes Infect. 2021. PMID: 34749573 Free PMC article.
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA).
Rusconi S, Adorni F, Tau P, Borghi V, Pecorari M, Maserati R, Francisci D, Monno L, Punzi G, Meraviglia P, Paolucci S, Di Biagio A, Bruzzone B, Mancon A, Micheli V, Zazzi M; ARCA (Antiviral Response Cohort Analysis). Rusconi S, et al. Among authors: micheli v. J Clin Virol. 2018 Aug;105:112-117. doi: 10.1016/j.jcv.2018.06.012. Epub 2018 Jun 21. J Clin Virol. 2018. PMID: 29957545
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees' sera: a preliminary evaluation.
Mileto D, Micheli V, Fenizia C, Cutrera M, Gagliardi G, Mancon A, Bracchitta F, De Silvestri A, Rizzardini G, Lombardi A, Biasin M, Gismondo MR. Mileto D, et al. Among authors: micheli v. Emerg Microbes Infect. 2022 Dec;11(1):790-792. doi: 10.1080/22221751.2022.2045878. Emerg Microbes Infect. 2022. PMID: 35196967 Free PMC article. No abstract available.
Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.
Mancon A, Rizzo A, Mileto D, Grosso S, Foschi A, Cutrera M, Capetti A, Faggion I, Anselmo A, Monte A, Fillo S, Rizzardini G, Gismondo MR, Micheli V. Mancon A, et al. Among authors: micheli v. Emerg Microbes Infect. 2022 Dec;11(1):786-789. doi: 10.1080/22221751.2022.2045877. Emerg Microbes Infect. 2022. PMID: 35209808 Free PMC article. No abstract available.
Role of multi-site sampling in the diagnosis of human Monkeypox.
Rizzo A, Mileto D, Moschese D, Candela C, Mancon A, Giacomelli A, Raccagni AR, Salari F, Cossu MV, Micheli V, Castagna A, Rizzardini G, Lombardi A, Nozza S, Gismondo MR. Rizzo A, et al. Among authors: micheli v. J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.12.010. Epub 2022 Dec 12. J Infect. 2023. PMID: 36521564 Free PMC article. No abstract available.
Viral bloodstream detection in mpox patients: An observational multicentric study.
Rizzo A, Moschese D, Trentacapilli B, Cossu MV, Giacomelli A, Salari F, Bianchi M, Raccagni AR, Micheli V, Gori A, Messina E, Antinori S, Gismondo MR, Castagna A, Mileto D, Rizzardini G, Lombardi A, Nozza S. Rizzo A, et al. Among authors: micheli v. J Infect. 2023 Jul;87(1):54-56. doi: 10.1016/j.jinf.2023.04.001. Epub 2023 Apr 6. J Infect. 2023. PMID: 37030631 No abstract available.
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy.
Piralla A, Mileto D, Rizzo A, Ferrari G, Giardina F, Gaiarsa S, Petazzoni G, Bianchi M, Salari F, Bracchitta F, Sammartino JC, Ferrari A, Gagliardi G, Mancon A, Fenizia C, Biasin M, Rovida F, Paolucci S, Percivalle E, Lombardi A, Micheli V, Nozza S, Castagna A, Moschese D, Antinori S, Gori A, Bonfanti P, Rossotti R, D'Arminio Monforte A, Attanasi F, Tirani M, Cereda D, Baldanti F, Gismondo MR; MPXV Lombardy Network. Piralla A, et al. Among authors: micheli v. Travel Med Infect Dis. 2024 May-Jun;59:102698. doi: 10.1016/j.tmaid.2024.102698. Epub 2024 Mar 29. Travel Med Infect Dis. 2024. PMID: 38556220 Free article.
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.
Saladini F, Meini G, Bianco C, Monno L, Punzi G, Pecorari M, Borghi V, Di Pietro M, Filice G, Gismondo MR, Micheli V, Penco G, Carli T, De Luca A, Zazzi M; ARCA Collaborative Group. Saladini F, et al. Among authors: micheli v. Clin Microbiol Infect. 2012 Oct;18(10):E428-30. doi: 10.1111/j.1469-0691.2012.03917.x. Epub 2012 Jun 21. Clin Microbiol Infect. 2012. PMID: 22716970 Free article.
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
Di Maio VC, Cento V, Di Paolo D, Aragri M, De Leonardis F, Tontodonati M, Micheli V, Bellocchi MC, Antonucci FP, Bertoli A, Lenci I, Milana M, Gianserra L, Melis M, Di Biagio A, Sarrecchia C, Sarmati L, Landonio S, Francioso S, Lambiase L, Nicolini LA, Marenco S, Nosotti L, Giannelli V, Siciliano M, Romagnoli D, Pellicelli A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Taliani G, Mastroianni C, Vespasiani-Gentilucci U, Romano M, Morisco F, Gasbarrini A, Vullo V, Bruno S, Baiguera C, Pasquazzi C, Tisone G, Picciotto A, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F; HCV Italian Resistance Network Study Group. Di Maio VC, et al. Among authors: micheli v. J Antimicrob Chemother. 2016 Mar;71(3):739-50. doi: 10.1093/jac/dkv403. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679249
247 results